+1 (202) 780-33972025: Volume 9, Issue 1
Commentary P.1-2
Emerging Frontiers in Tumor Suppressor Research: From Bench to Bedside
Author(s):
Dr. Hudan Liu
DOI: 10.35841/AAMOR.9.1.271
Commentary P.1-1
Revolutionizing cancer research: the role of single-cell multi-Omics in oncology
Author(s):
John Shen*
DOI: 10.35841/aamor-9.1.271
Editorial P.1-2
Revolutionizing cancer treatment: The synergy of ai-driven genomics and crispr-based oncogene editing
Author(s):
Ahana Bhat*
DOI: 10.35841/aamor-9.1.272
Opinion Article P.1-2
Exosome derived biomarkers in cancer: Targeting oncogenic rna modifications for precision medicine
DOI: 10.35841/aamor-9.1.273
Perspective P.1-2
Immunometabolism in the tumor microenvironment and neoantigen-based cancer vaccines: A new era in cancer therapy
Author(s):
Jackie Wong*
DOI: 10.35841/aamor-9.1.274
Rapid Communication P.1-2
Exploring synthetic lethality and microbiome-cancer interactions: A new frontier in oncology
Author(s):
Ling Cai*
DOI: 10.35841/aamor-9.1.275
Short Communication P.1-2
Epitranscriptomics and liquid biopsy: Advancing early cancer detection and understanding tumor progression
Author(s):
Gress Goel*
DOI: 10.35841/aamor-9.1.276
Commentary P.1-2
Advancing drug discovery: The role of non-coding rna therapeutics and organoid models for drug screening
Author(s):
Robert Chen*
DOI: 10.35841/aamor-9.1.277
Editorial P.1-2
Ai-guided precision oncology: Transforming cancer treatment with car-nk cell therapy
Author(s):
Liam Mesi*
DOI: 10.35841/aamor-9.1.278
Original Article P.1-2
Mitochondrial Targeting in Cancer Therapy: Overcoming Hypoxia-Induced Tumor Resistance
Author(s):
Adam Eggar*
DOI: 10.35841/aamor-9.1.279
Perspective P.1-2
Exploring DNA damage response pathways and the role of long non-coding rnas in tumorigenesis
Author(s):
Mallory Taylor*
DOI: 10.35841/aamor-9.1.280